Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1

Human immunodeficiency virus type 1 (HIV-1) vaccine development requires selection of appropriate envelope (Env) immunogens. Twenty HIV-1 Env glycoproteins were examined for their ability to bind human anti-HIV-1 monoclonal antibodies (MAbs) and then used as immunogens in guinea pigs to identify pro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liao, Hua-Xin, Tsao, Chun-Yen, Alam, S. Munir, Muldoon, Mark, Vandergrift, Nathan, Ma, Ben-Jiang, Lu, Xiaozhi, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy, Parks, Robert, Chen, Haiyan, Blinn, Julie H., Lapedes, Alan, Watson, Sydeaka, Xia, Shi-Mao, Foulger, Andrew, Hahn, Beatrice H., Shaw, George M., Swanstrom, Ron, Montefiori, David C., Gao, Feng, Haynes, Barton F., Korber, Bette
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3624376/
https://ncbi.nlm.nih.gov/pubmed/23365441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02297-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars